Lam Research Unleashes $25 Billion Stock Buyback

Lam Research announced a $25 billion stock buyback program, but the authorization is flexible and non-binding. The company's board approved repurchases up to $25 billion, with no expiration date or obligation to spend the full amount. Buybacks can boost earnings per share without increasing profits, but actual repurchases may not match the authorized amount. The announcement follows a semiconductor selloff, reflecting management's capital-return flexibility.

Nasdaq 100 rebounded 2.5% after a 5.5% drop, with tech and semiconductor stocks leading the recovery. Lam Research surged 12% after a $25B share buyback and dividend announcement. Moderna rose 4% on strong Q3 results and raised 2026 revenue growth outlook to 15-25%.

Lam Research (LRCX) shares rose 9% after its board approved a $25 billion buyback, exceeding ASML (ASML) and Applied Materials (AMAT) in the chip-equipment rebound. Analysts expect Lam's earnings to more than double by fiscal 2028. The buyback reflects confidence in chipmakers' continued investment in Lam's tools, with KLA (KLAC) and TSMC (TSM) as key indicators of future spending.

Lam Research (LRCX) surged 10.8% after announcing a $25B share buyback and $0.33 dividend. Analysts view the move as a confidence signal, with 26 Buy ratings. The stock rebounded amid a broader tech rally, supported by strong jobs data. LRCX reached $209.18 before settling near $205.25.

Lam Research (LRCX) shares rebounded 11% premarket after a $25B share buyback authorization, following a 16.4% drop. LYNX Equity suggests the semiconductor rout may be a buying opportunity, citing supply constraints and potential further buybacks. Other affected stocks include Micron (MU), AMD (AMD), and SanDisk (SNDK).

Lam Research's board approved a $25 billion share repurchase program and a $0.33 per share quarterly dividend. The dividend is payable on January 6, 2027, to shareholders of record on December 2, 2026.